Jeongsoo Won

Jeongsoo Won

Auto-generated profile, based on publicly available information

Jeongsoo Won

Graduate School of Medical Science, Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2025 in Journal of Hepatology
Verified
Journal Article
Closed access
TCTaek Chung
Taek Chung
SOSeungho Oh
Seungho Oh
JWJeongsoo Won
Jeongsoo Won
JPJiho Park
Jiho Park
JYJeong Eun Yoo
Jeong Eun Yoo
YPYoung Nyun Park
Young Nyun Park

27 August 2025 in Clinical and Translational Medicine
Verified
Journal Article
Open access
JWJeongsoo Won
Jeongsoo Won
YCYeon Seung Chung
Yeon Seung Chung
SJSe-Young Jo
Se-Young Jo
JPJiho Park
Jiho Park
HSHyo Sup Shim
Hyo Sup Shim
SKSangwoo Kim
Sangwoo Kim
•MeTel is a novel Bayesian algorithm that accurately classifies multifocal lung cancers.

6 August 2026 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
HOHyeong-Cheol Oh
Hyeong-Cheol Oh
RCRan Joo Choi
Ran Joo Choi
SJSe-Young Jo
Se-Young Jo
EYEunchae Yeo
Eunchae Yeo
EJEuna Jo
Euna Jo
SKSeok-Gu Kang
Seok-Gu Kang
Glioblastoma (GBM) remains lethal despite maximal therapy. The adult subventricular zone (SVZ), a neural stem-cell niche, has been implicated as a potential site of origin, yet the identity and functional properties of putative GBM origin-like cells (GBM-OCs) within the SVZ remain unclear. An SVZ-restricted somatic mutation mouse model (Cre-induced EGFRvIII expression with Trp53 and Pten disruption) was established and mouse SVZ-derived cells were prospectively isolated for functional and molecular profiling. Self-renewal, multipotency, invasive potential and tumour-initiating capacity were assessed relative to control SVZ cells and matched tumour-derived tumourspheres. Whole-genome and RNA sequencing defined genomic and transcriptional alterations during early progression. Mouse GBM-OCs exhibited self-renewal and multilineage differentiation and initiated tumours only after re-implantation into the SVZ (11/29, 38%), whereas direct striatal implantation failed (0/25, 0%), indicating context-dependent tumorigenic potential associated with the SVZ microenvironment. In contrast, tumour-derived tumourspheres retained tumorigenic capacity upon implantation into both the SVZ and the striatum. During progression from mouse GBM-OCs to tumours, whole-chromosome and arm-level aneuploidies accumulated. In patients with GBM, multi-region single-nucleus RNA sequencing of tumour-free SVZ, matched tumours and tumour-free cortex identified rare neural stem cell-like, astrocyte-like and oligodendrocyte precursor-like SVZ populations transcriptionally aligned with GBM programmes. These cells showed single-nucleus RNA-inferred chromosome 7 gain and/or chromosome 10 loss signals, with concordant low-frequency copy-number alterations in the SVZ detected by exome sequencing and enriched in matched tumours. Together, these findings support the presence of SVZ-resident stem or progenitor-like populations with early GBM-associated features, consistent with putative GBM-OCs, and highlight the SVZ niche as a potential target for early detection and niche-informed therapeutic strategies.